New U.S. Food and Drug Administration (FDA) regulations imposed upon the controversial diabetes drug Avandia will prohibit local retail pharmacies to carry the medication due to a confirmed risk for heart attack and other cardiovascular complications.
This motion applies to three anti-diabetes drugs manufactured by GlaxoSmithKline, Avandia, Avandamet and Avandaryl, that contain rosiglitazone - a drug that increases sensitivity to insulin and removes extra glucose from blood.
ATTORNEY ADVERTISEMENT: Not available in all states. Joshua S. Parilman, supervising attorney is licensed only in CA and AZ, but associates with licensed attorneys as necessary throughout the country. Court costs and expenses may be the responsibility of the client. Prior results do not guarantee a similar outcome. The Wyoming State Bar does not certify any lawyer as a specialist or expert. Anyone considering a lawyer should independently investigate the lawyer’s credentials, and not rely upon advertisements or self-proclaimed expertise. Services may be performed by other lawyers and individuals within the firm. Before you decide, ask us to send you free information about our qualifications and expertise. No representation is made that the quality of the legal services performed is greater than the quality of the legal services performed by other lawyers. FREE BACKGROUND INFORMATION AVAILABLE UPON REQUEST. We are not accepting cases in states where this ad conflicts with laws or state rules.
Any medical decision is important. Please consult your physician. Please consult your physician before you discontinue the use of any medication.
Principal Office: 2020 N. Central Avenue, Suite 1100, Phoenix, AZ 85004